Table 5.
Advantages | Disadvantages |
---|---|
Variety of different target autoantigens (>100) | Subjectivity |
Some autoantibodies can be identified without confirmatory testing (i.e., anti-centromere) | Poorly standardized across manufacturers |
Discovery tool for novel autoantibodies | Requires training and expertise |
Useful for a spectrum autoimmune diseases (i.e., autoimmune hepatitis) | Low sensitivity for certain clinically important autoantibodies (i.e., Jo-1, ribosomal P, SS-A/Ro60, Ro52/TRIM21) |
Low specificity (high false positive rate) |